It develops when inflammation targets cartilage and similar tissues in episodes that come and go over months and years. Repeated flares can gradually damage and deform the affected cartilage. The condition may involve one area or several organs, and its course ranges from mild, intermittent symptoms to severe disease that threatens breathing, hearing, vision or the heart. Without appropriate assessment and management, relapsing polychondritis can lead to permanent ear or nasal deformity, hearing loss, airway narrowing, eye damage, heart valve and aortic disease and, in severe cases, life-threatening complications.
What is relapsing polychondritis?
Relapsing polychondritis is a chronic, immune-mediated inflammatory condition that primarily affects cartilage. It is characterised by recurrent flares of inflammation (chondritis), interspersed with periods of relative or complete quiet.
- Cartilage is a firm, flexible tissue that shapes the ears, nose and windpipe and cushions the joints.
- In relapsing polychondritis, immune cells and antibodies target cartilage proteins such as type II collagen, triggering inflammation and gradual breakdown of the tissue.
- Similar proteins are found in the eye, inner ear, heart valves and blood vessel walls, so the condition can affect organs beyond cartilage.
It is rare, affects men and women equally, and typically begins between the ages of 40 and 60.
What are the causes of relapsing polychondritis?
The exact cause is not known. It is thought to arise when the immune system loses tolerance to the body's own cartilage in genetically susceptible people. It is not contagious and is rarely inherited.
Factors associated with relapsing polychondritis include:
Immune and genetic factors
- Autoimmunity directed against cartilage proteins, including type II collagen
- An association with the HLA-DR4 tissue type, although most people with it never develop the condition
Associated conditions
- Other autoimmune diseases, present in around a third of people, including ANCA-associated vasculitis, rheumatoid arthritis, lupus and SjΓΆgren's disease
- Myelodysplastic syndrome, more often seen when the condition begins in later life
- VEXAS syndrome, an autoinflammatory condition caused by an acquired UBA1 gene mutation, which mainly affects older men and can closely resemble relapsing polychondritis
What are the symptoms of relapsing polychondritis?
Symptoms often begin suddenly, with flares lasting days to weeks. Several areas may be involved at once or at different times. Symptoms may include:
- Ear inflammation, causing sudden pain, redness or purple discolouration and swelling of the upper ear, typically sparing the earlobe, which contains no cartilage
- Nasal inflammation, causing pain and crusting and, with repeated attacks, collapse of the nasal bridge (saddle-nose deformity)
- Joint pain and swelling, and chest wall pain from inflammation of the rib cartilage
- Eye inflammation, causing a red, painful eye, light sensitivity or blurred vision
- Airway symptoms, including hoarseness, cough, noisy breathing or breathlessness
- Inner ear symptoms, including hearing loss, tinnitus and vertigo
- Heart valve or aortic involvement, which may cause breathlessness or chest pain
- Fever, fatigue and weight loss during active disease
Because the condition is rare and overlaps with many others, diagnosis is often delayed.
When to Seek Medical Advice?
You should seek specialist assessment if you have:
- Recurrent, unexplained painful swelling or redness of the ears or nose
- Inflammatory joint pain together with ear, nose or eye inflammation
- A persistent hoarse voice, cough or breathlessness without a clear cause
- Hearing loss or vertigo alongside other inflammatory symptoms
Difficulty breathing, sudden hearing loss, a painful red eye with change in vision, or new chest pain are urgent and need immediate medical attention.
Early assessment allows treatment before permanent cartilage damage, airway narrowing or organ complications develop.
How relapsing polychondritis is diagnosed?
There is no single test, and diagnosis rests on recognising a characteristic pattern of features, supported by investigations that exclude other conditions and assess the extent of disease. Dr Nuttall will begin with a detailed review of your symptoms, medical history and family history, and a physical examination of the ears, nose, eyes, joints and chest.
Investigations for relapsing polychondritis may include:
Initial assessment
- Blood tests, including inflammatory markers, full blood count, kidney function and autoantibodies such as ANA, rheumatoid factor and ANCA
- Urine tests, to look for blood or protein suggesting kidney involvement
- UBA1 genetic testing, where VEXAS syndrome is suspected, particularly in older men with anaemia
Further imaging and specialist investigations
- Lung function tests and CT scanning of the chest, to assess airway narrowing or collapse
- Echocardiography and CT or MR angiography, to assess the heart valves and aorta
- PET-CT scanning, to identify active cartilage inflammation and guide biopsy
- Audiometry and ophthalmology review, where hearing or eye symptoms are present
- Biopsy of affected cartilage, where the diagnosis remains uncertain
How to treat relapsing polychondritis?
Treatment is aimed at controlling inflammation during flares, preventing relapses, protecting vital organs and preserving cartilage. The approach is tailored to the sites involved, the severity of disease and your overall health.
Treatment options may include:
Medical management
- Non-steroidal anti-inflammatory drugs, which may be sufficient for mild disease
- Colchicine or dapsone, to reduce the frequency of flares in milder disease
- Corticosteroids such as prednisolone, the mainstay for moderate to severe flares, tapered to the lowest effective dose
- Steroid-sparing agents, such as methotrexate, azathioprine or mycophenolate, to maintain control and reduce long-term steroid exposure
- Biologic therapies, such as TNF inhibitors, tocilizumab or rituximab, when disease is severe or resistant to conventional treatment
- Cyclophosphamide, reserved for organ-threatening disease
Monitoring and supportive care
- Regular monitoring of symptoms, inflammatory markers, lung function and hearing
- Bone protection for people on corticosteroids, including calcium, vitamin D and bone density assessment
- Cardiology review and periodic imaging, to monitor the heart valves and aorta
- Airway stenting, surgery or valve repair, for severe airway narrowing or valve disease
Dr Nuttall will tailor treatment to control disease activity, relieve symptoms, and reduce the risk of long-term complications affecting your cartilage, airways and vital organs.
